Canopy Growth (TSX:WEED) Has Never Had More Value Than it Does Now

The cannabis space has been a tough one for investors who try and trade the market. It’s extremely volatile and impossible to time, with minor news stories moving stocks large percentages.

The length of time it has taken for the industry to get on its feet and for a lot of the producers to start earning a profit have also been a bit of a shock to the market.

Although it seems like the industry is not for long-term value investors, I believe that’s exactly who would do best to own these companies.

It takes investors who will do the work to identify the best companies and their fair values, and then it takes the patience to hold them for when the industry will actually mature in the long term.

One of the best stocks out there has been an industry leader since day one and continues to offer investors the most potential is Canopy Growth (TSX:WEED)(NYSE:CGC).

Canopy Growth has been the leader in the cannabis space since it was the first publicly traded cannabis stock in Canada. Since then, it has led the pack with the domestic acquisitions, foreign partnerships, major capex on research and development, deals with celebrities, and so on.

In the last few years since the stock began its incredible rise, some investors may have felt like they missed the bus. Now, however, after coming off its all-time high of $76, the company is the cheapest it’s been in a while, trading at the bottom of its 52-week low of about $33.

Stock price is cheap

This is the cheapest Canopy has been in over a year, and when you take into account its fair value has been rising and is much higher now that cannabis has been legalized, it looks as though Canopy could be at its biggest discount to fair value possibly since the company was founded.

Another sign that Canopy is an absolute steal at these prices is that the ousted CEO and founder of the company Bruce Linton continues to buy more shares. Linton was ousted by the board after it was clear the performance of the company (and lack of profitability) was not up to the board’s standards.

Linton, however, knows the company inside and out. He built it and ran it until his departure, and he is the primary person responsible for making all the deals and shaping the company. If he is willing to bet his personal money investing at these prices, it seems rather obvious that the company is undervalued.

Room for growth

Canopy, especially while still under Linton, made it clear that it sees world growth and growth in the medical sector to be the next big wave of changes. It has positioned itself well with a number of international deals, getting its foot in the door before big changes are implemented, which will bring big opportunities.

Another avenue for growth the company has is the numerous paths it could go down with respect to each of the deals it has with celebrities. Each partnership, such as the one with Snoop Dogg, provides Canopy with limitless opportunities. One simple partnership can open the opportunity for collaboration on dry bud, extract, edibles, clothing, accessories, and more.

Potential takeover target

Another positive for long-term investors is the potential for Canopy to be taken out, especially if it starts performing to the level a lot of investors initially expected.

Continued growth and domination of the industry in Canada will naturally push the stock price up, as retail investors pile into it, but if Canopy can truly show its dominance, a larger company, such as Constellation Brands, which owns 37% of the Canopy right now, may want to fully take it over. This would be huge for investors, as the premium Constellation would have to pay would be massive.

Bottom line

Canopy has a lot of catalysts going for it right now. The new direction of the company coupled with the ultra-low stock price and continued growth in the industry worldwide are all big reasons why the stock could easily double over the next year. For investors wanting to get into the cannabis space, there is no better time.

One tiny small-cap stock to bet on ahead of Cannabis 2.0 on October 17th…

The first wave of cannabis legalization minted millionaires out of everyday investors, and it might be about to happen again.

Because when edibles are legalized in Canada on October 17th, experts project a new $2.7 BILLION market will be born.

Our last legalization stock pick is already up 1,211%, and now we’re recommending one tiny small-cap stock before Cannabis 2.0.

This could be our next +1,000% winner in the cannabis space.

Hurry, the second wave of cannabis legalization is about to hit and this stock could skyrocket.

Click here to learn more!

More reading

Fool contributor Daniel Da Costa has no position in any of the stocks mentioned.

Source: The Fool
Canopy Growth (TSX:WEED) Has Never Had More Value Than it Does Now
The Fool

The Motley Fool
Contributor at
The Motley Fool is dedicated to helping the world invest — better. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, mutual funds, and premium investing services.

In all we do, we take a different approach.

We believe – and have proven over decades – that the individual investor can beat the market.

We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.

We believe in a long-term outlook, helping people build wealth over time.

We believe that the person best positioned to take care of your financial future is you.

And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.

While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.

Related News